Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.14 +0.00 (+0.00%)
As of: Aug 21, 2026 · 2:38 PM EDT

Drugs Made In America Acquisition (DMII) Net Income (2025)

Drugs Made In America Acquisition (DMII) posted quarterly Net Income of $4.6 million for Q4 2025, up 10041.88% quarter-over-quarter from -$46158.0 in Q3 2025.

Drugs Made In America Acquisition (DMII) Net Income (2025) Analysis & Trends

Drugs Made In America Acquisition (DMII) has reported Net Income for 1 consecutive years, with $4.6 million the latest figure, recorded in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 2.11 Mn
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - 1.95 Mn
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 4.40 Mn
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - 3.92 Mn
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 290,121.00
6 Aldel Financial 397.49 Mn 397.49 Mn - 2.11 Mn
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - 2.65 Mn
8 Gores Holdings X 385.06 Mn 384.87 Mn - 1.88 Mn
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - -
10 CSLM Digital Asset Acquisition Corp III 322.52 Mn 314.90 Mn - -623,674.00

Historic Data

Download Data
DateValue
Dec 31, 2025 4.59 Mn
Sep 30, 2025 -46,158.00